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A 37-year-old lady was referred to rheumatology (Treliske Hospital, Truro) in 2015 
following 8 months of rib pain, initially thought to be costochondritis. She had isolated 
hypophosphataemia (0.50mmol/L) and a pelvic MRI identified stress fractures 
(Figure 1a). 14 months after her presentation she had a persistent low phosphate, 
with normal PTH,serum calcium and 25(OH)vitamin D of 32ng/mL. It was concluded 
that “she has subclinical [vitamin D] deficiency” and she was administered 
cholecalciferol 20,000 units/week and SandoPhos, 2 tablets BD. In March 2016, still 
symptomatic, she was referred to the UCL Centre for Nephrology to investigate a 
possible renal cause for the hypophosphataemia.  
There, her calculated urinary fractional excretion of phosphate was raised at 42%, 
confirming hyperphosphaturia. Her gender and age weighed against X-linked, 
autosomal dominant, or recessive hypophosphtaemic rickets; normal excretion of 
low molecular weight protein, urate and glucose ruled out the renal Fanconi 
syndrome. The serum concentration of FGF23 was 180RU/ml (NR 0-150). Previous 
standard practice protocolled a first-line FDG PET/CT scan, which identified a nasal 
cavity mass which was avid on a subsequent 68Ga DOTATATE PET/CT (Figure 1b).  
The tumour was excised and pathology confirmed “Sinonasal mucosa [with] 
evidence of phosphaturic mesenchymal tumour”; her serum phosphate and FCF23 
returned to normal.   
Oncogenic osteomalacia is a paraneoplastic syndrome usually associated with 
mesenchymal tumours, although somatic mutations in adenocarcinomas causing this 
syndrome have been reported. Phosphatonins (e.g. FGF23) decrease renal 
resorption of phosphate, leading to hypophosphataemia, muscle weakness and 
osteomalacia. Most tumours are located in bone and soft tissue, solitary, and rarely 
cause local symptoms often making the diagnosis long and difficult. Use of 
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radiolabelled somatostatin analogues (such as octreotate, as in a 68GA-DOTATATE 
scan) is the most sensitive and specific functional imaging.  
The only definitive management is removal of the phosphaturic mesenchymal 
tumour; recurrence is rare but has been described.  
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Figure Legend: Oncogenic Osteomalacia 
(A) MRI of sacrum showing stress fractures (indicated by arrow) (B) 68Ga-
DOTATATE PET/CT scan showing intense uptake in soft tissue lesion in the left 
nasal cavity and ethmoid sinus.  
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Challenging question 
A 37-year old female presented with bone pain affecting her legs. There was no past 
medical history and she took no regular medications. A bone scan showed 
widespread increased uptake consistent with osteomalacia. Her serum phosphate 
was low at 0.3 mmol/L. Serum calcium, PTH and vitamin D were all normal. Urine 
analysis showed an increased excretion of phosphate (fractional excretion 45%) but 
normal urinary urate and glucose, with undetectable protein. What is the most likely 
diagnosis? 
 
 
 
(a) X-linked hypophosphatemic rickets 
(b) Fanconi syndrome 
(c) Oncogenic osteomalacia 
(d) Vitamin D deficiency 
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